Asston Pharmaceuticals Share Price
97.54+4.64 (+4.99%)
+4.38% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
LAURUSLABS-ANSE
CIPLA-ANSE
DRREDDY-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
APL-MTNSE
Asston Pharmaceuticals Share Price
97.54+4.64 (+4.99%)
+4.38% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | 38% | 61% |
| - | - | 239% | 218% |
| - | - | - | 4% |
| 42% | 42% | 52% | 51% |
Peer Comparison
Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
ZYDUSLIFE-A
LAURUSLABS-A
CIPLA-A
DRREDDY-A
MANKIND-A
AUROPHARMA-A
LUPIN-A
APL-MT
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,748.9 | ₹424466 Cr | 35.09 | 12.07 | 62.82 | ₹11479 Cr |
| 9,029.85 | ₹246222 Cr | 84.18 | 34.04 | 128.41 | ₹2568 Cr |
| 4,594 | ₹176301 Cr | 80.83 | 16.72 | 97.06 | ₹2163 Cr |
| 1,124 | ₹112818 Cr | 25 | 9.42 | 62.53 | ₹5040 Cr |
| 2,036 | ₹110823 Cr | 101.36 | 6.8 | 29.25 | ₹889 Cr |
| 1,312.85 | ₹107447 Cr | 31.88 | 9.77 | 57.87 | ₹3879 Cr |
| 1,214.1 | ₹103471 Cr | 32.11 | 5.32 | 63.99 | ₹4196 Cr |
| 2,330.1 | ₹97850 Cr | 47.9 | 13.75 | 71.08 | ₹1913 Cr |
| 1,659.9 | ₹96836 Cr | 26.08 | 17.95 | 96.84 | ₹3505 Cr |
| 1,954.8 | ₹89629 Cr | 16.21 | 30.95 | 154.35 | ₹5333 Cr |
| 97.54 | ₹101 Cr | 26.26 | — | 3.83 | ₹4 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| — | — | — | — |
| ₹6 Cr | ₹78 L | ₹70 L | ₹70 L |
| ₹4 Cr | ₹6 Cr | ₹1 Cr | ₹23 L |
| ₹4 Cr | ₹6 Cr | ₹1 Cr | ₹23 L |
| ₹11 Cr | ₹6 Cr | ₹2 Cr | ₹93 L |
| ₹14 L | ₹91 L | ₹97 L | ₹69 L |
| ₹2 Cr | ₹72 L | ₹85 L | ₹25 L |
| -₹2 L | ₹2 L | ₹3 L | ₹2 L |
| ₹16 L | ₹16 L | ₹7 L | ₹5 L |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr |
| — | — | — | — |
| ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr |
| ₹3 Cr | ₹83 L | ₹45 L | ₹51 L |
| ₹4 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr |
| ₹2 Cr | ₹86 L | ₹67 L | ₹20 L |
| ₹15 Cr | ₹12 Cr | ₹10 Cr | ₹8 Cr |
| ₹28 Cr | ₹20 Cr | ₹14 Cr | ₹9 Cr |
| ₹7 Cr | ₹7 Cr | ₹5 Cr | ₹3 Cr |
| — | — | — | — |
| ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹94 L |
| ₹14 L | ₹11 L | ₹6 L | ₹3 L |
| ₹96 L | ₹1 Cr | ₹1 Cr | ₹92 L |
| ₹13 L | ₹13 L | ₹1 Cr | ₹1 Cr |
| ₹0 | ₹71 L | ₹67 L | ₹0 |
| ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr |
| — | — | — | — |
| ₹72 L | ₹1 Cr | ₹2 Cr | ₹50 L |
| ₹25 Cr | ₹16 Cr | ₹9 Cr | ₹6 Cr |
| ₹20 L | ₹64,000 | ₹12 L | ₹14 L |
| ₹1 L | ₹0 | ₹0 | ₹0 |
| ₹2 Cr | ₹74 L | ₹46 L | ₹34 L |
| ₹27 Cr | ₹18 Cr | ₹11 Cr | ₹7 Cr |
| ₹12 Cr | ₹6 Cr | ₹91 L | -₹18 L |
| ₹28 Cr | ₹20 Cr | ₹14 Cr | ₹9 Cr |
| ₹17 | ₹82 | ₹28 | ₹13 |
| ₹17 | ₹10 | ₹4 | ₹2 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| ₹6 Cr | ₹2 Cr | ₹1 Cr | ₹16 L |
| ₹93 L | ₹94 L | ₹75 L | ₹44 L |
| -₹7 Cr | -₹6 Cr | -₹2 Cr | -₹2 Cr |
| -₹17 L | -₹3 Cr | -₹30 L | -₹1 Cr |
| -₹16 L | -₹4 Cr | -₹32 L | -₹1 Cr |
| ₹87 L | -₹54,000 | -₹91 L | -₹20,000 |
| -₹51 L | ₹4 Cr | ₹1 Cr | ₹1 Cr |
| ₹19 L | -₹12 L | -₹1 L | ₹10 L |
| ₹63,000 | ₹12 L | ₹14 L | ₹3 L |
| ₹20 L | ₹64,000 | ₹12 L | ₹14 L |
Fundamental Ratios
Consolidated
Standalone
No results found
Asston Pharmaceuticals Share Price
97.54+4.64 (+4.99%)
+4.38% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 3 out of 9 oscillators
RSI
48.59Neutral
STOCH %K
49.42Neutral
MACD Level(12,26)
-1.07Sell
Ultimate Oscillator
53.27Buy
Aroon Oscillator
44.00Sell
BOP
1.00Buy
CCI
-70.38Neutral
Williams %R
-50.58Neutral
Momentum
-4.46Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 6
Bearish signals: 3 out of 9 moving averages
EMA 9
96.65Buy
SMA 9
96.38Buy
EMA 21
98.53Sell
SMA 21
100.59Sell
EMA 50
95.32Buy
SMA 50
96.20Buy
EMA 200
89.98Buy
SMA 200
84.03Buy
WMA 20
97.78Sell
Pivot
Pivot
Classic
Resistance 5
120.38
Resistance 4
113.63
Resistance 3
106.88
Resistance 2
100.13
Resistance 1
96.52
Pivot
93.38
Support 1
89.77
Support 2
86.63
Support 3
79.88
Support 4
73.13
Support 5
66.38
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Asston Pharmaceuticals Share Price
97.54+4.64 (+4.99%)
+4.38% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Mar 2026 | Sep 2025 | Jul 2025 |
|---|---|---|
| 50.66% | 50.66% | 50.66% |
| 1.91% | 6.04% | 9.71% |
| 0.00% | 0.00% | 1.43% |
| 0.00% | 0.00% | 0.00% |
| 47.43% | 43.30% | 38.20% |
Bulk & block deals
Name
Prakruti R Pali
Prakruti R Pali
Snehlata Manoj Kathotia
Prakruti R Pali
Prakruti R Pali
Prakruti R Pali
Snehlata Manoj Kathotia
Vanita Anilkumar Kumbhare
Dilip Rameshchandra Jagad
Prakruti R Pali
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 01 Sep 2026 | Purchase | 62.75 L | ₹123.04 | 51 K | Bulk | 0.599126 | BSE |
| 31 Aug 2026 | Purchase | 1.24 Cr | ₹123.88 | 1 L | Bulk | 1.174757 | BSE |
| 31 Aug 2026 | Purchase | 51.21 L | ₹119.10 | 43 K | Bulk | 0.505145 | BSE |
| 28 Aug 2026 | Purchase | 1.85 Cr | ₹112.81 | 1.64 L | Bulk | 1.926601 | BSE |
| 27 Aug 2026 | Purchase | 2.49 Cr | ₹103.69 | 2.40 L | Bulk | 2.819416 | BSE |
| 26 Aug 2026 | Purchase | 1.32 Cr | ₹95.59 | 1.38 L | Bulk | 1.621164 | BSE |
| 20 Aug 2026 | Purchase | 54.73 L | ₹81.68 | 67 K | Bulk | 0.787087 | BSE |
| 20 Aug 2026 | Sell | 56.73 L | ₹81.04 | 70 K | Bulk | 0.82233 | BSE |
| 17 Jul 2026 | Sell | 66.55 L | ₹66.55 | 1 L | Bulk | 1.174757 | BSE |
| 12 Jun 2026 | Purchase | 58.81 L | ₹78.41 | 75 K | Bulk | 0.881068 | BSE |
Insider trading & SAST
Client name
Prakruti R Pali
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23 Sep 2026 | Other | Acquisition | 2.82 | 5.33 | 0 | — | 2.40 L | 27 Aug 2026 | Market | 4,54,000 | SAST | 29(1) | — |
Asston Pharmaceuticals Share Price
97.54+4.64 (+4.99%)
+4.38% past 1 Year
Asston Pharmaceuticals is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African markets. The company operates under brand ‘Asston’. The company
Corporate Actions
Date
Type
Details
Company details
Asston Pharmaceuticals Share Price
97.54+4.64 (+4.99%)
+4.38% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
No presentations found
Asston Pharmaceuticals Share Price
97.54+4.64 (+4.99%)
+4.38% past 1 Year
News
Asston Pharmaceuticals informs about appointment of statutory auditors
Equity
APL
Asston Pharmaceuticals receives order for supplying various pharma products
Equity
APL
Asston Pharmaceuticals receives purchase order from Pharma company in west Africa
Equity
APL
Asston Pharmaceuticals bags purchase order worth Rs 6.52 crore
Equity
APL